{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T22:44:46Z","timestamp":1792622686967,"version":"4.5.0"},"reference-count":51,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2019,1,18]],"date-time":"2019-01-18T00:00:00Z","timestamp":1547769600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0210988","type":"journal-article","created":{"date-parts":[[2019,1,18]],"date-time":"2019-01-18T18:25:57Z","timestamp":1547835957000},"page":"e0210988","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":35,"title":["Effect of evidence-based therapy for secondary prevention of cardiovascular disease: Systematic review and meta-analysis"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1361-4055","authenticated-orcid":true,"given":"Tian-Tian","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian C. K.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth K. C.","family":"Man","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Crake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhiddin A.","family":"Ozkor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling-Qing","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-Xuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,1,18]]},"reference":[{"key":"ref1"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","year":"2002","journal-title":"BMJ"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0140-6736(15)01225-8","article-title":"Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis","volume":"387","author":"D Ettehad","year":"2016","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.2015.15629","article-title":"Statins for Prevention of Cardiovascular Disease in Adults","volume":"316","author":"R Chou","year":"2016","journal-title":"JAMA"},{"key":"ref5","unstructured":"WHO. Secondary prevention of noncommunicable diseases in low- and middle-income countries through community-based and health service interventions: World Health Organization-Wellcome Trust meeting report, 1\u20133 August 2001. 2002; Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/iris\/handle\/10665\/42567\" xlink:type=\"simple\">http:\/\/www.who.int\/iris\/handle\/10665\/42567<\/ext-link>"},{"key":"ref6","article-title":"Myocardial infarction: cardiac rehabilitation and prevention of further cardiovascular disease","year":"2013"},{"key":"ref7","article-title":"Stroke rehabilitation in adults","year":"2013"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s12471-018-1134-0","article-title":"2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: comments from the Dutch ACS working group","volume":"26","author":"F Arslan","year":"2018","journal-title":"Netherlands Hear J"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1016\/j.jacc.2014.09.017","article-title":"2014 AHA\/acc guideline for the management of patients with Non-ST-Elevation acute coronary syndromes: A report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"64","author":"EA Amsterdam","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1161\/STR.0000000000000024","article-title":"Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack","volume":"45","author":"WN Kernan","year":"2014","journal-title":"Stroke"},{"key":"ref11","first-page":"1","article-title":"A strategy to reduce cardiovascular disease by more than 80%","volume":"326","author":"NJ Wald","year":"2003","journal-title":"BMJ"},{"key":"ref12","article-title":"Fixed-dose combination therapy for the prevention of atherosclerotic cardiovascular diseases","author":"E Bahiru","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"418","DOI":"10.5414\/CP201667","article-title":"Impact of evidence-based cardiac medications on short and long-term mortality in 7,567 acute coronary syndrome patients in the Gulf RACE-II registry","volume":"50","author":"I Al-Zakwani","year":"2012","journal-title":"Int J Clin Pharmacol Ther"},{"key":"ref14","first-page":"655","article-title":"Long-term survival in patients with different combinations of evidence-based medications after incident acute myocardial infarction: results from the MONICA\/KORA Myocardial Infarction Registry","volume":"103","author":"U Amann","year":"2014","journal-title":"Clin Res Cardiol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1097\/HJR.0b013e328338e5da","article-title":"Guideline-recommended secondary prevention drug therapy after acute myocardial infarction: predictors and outcomes of nonadherence","volume":"17","author":"T Bauer","year":"2010","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/pds.4171","article-title":"Comparative effectiveness of recommended versus less intensive drug combinations in secondary prevention of acute coronary syndrome","volume":"26","author":"J Bezin","year":"2017","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1136\/hrt.2009.188607","article-title":"The effect of optimal medical therapy on 1-year mortality after acute myocardial infarction","volume":"96","author":"P Bramlage","year":"2010","journal-title":"Heart"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement","volume":"4","author":"D Moher","year":"2015","journal-title":"Syst Rev"},{"key":"ref19","article-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0","author":"JP Higgins","year":"2011","journal-title":"The cochrane collaboration"},{"key":"ref20","doi-asserted-by":"crossref","DOI":"10.1186\/s12913-014-0579-0","article-title":"PICO, PICOS and SPIDER: A comparison study of specificity and sensitivity in three search tools for qualitative systematic reviews","volume":"14","author":"AM Methley","year":"2014","journal-title":"BMC Health Serv Res"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"A Stang","year":"2010","journal-title":"Eur J Epidemiol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1111\/apt.13211","article-title":"Systematic review with meta-analysis: the association between the use of calcium channel blockers and gastrointestinal bleeding","volume":"41","author":"Y He","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"R DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"ref24","first-page":"271","article-title":"Graphical Display of Estimates Having Differing Standard Errors","volume":"30","author":"G Display","year":"2015"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ahj.2013.04.011","article-title":"The combined use of aspirin, a statin, and blood pressure-lowering agents (polypill components) and the risk of vascular morbidity and mortality in patients with coronary artery disease","volume":"166","author":"M Lafeber","year":"2013","journal-title":"Am Heart J"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.ahj.2010.03.009","article-title":"Suboptimal use of evidence-based medical therapy in patients with acute myocardial infarction from the Korea Acute Myocardial Infarction Registry: Prescription rate, predictors, and prognostic value","volume":"159","author":"JH Lee","year":"2010","journal-title":"Am Heart J"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1212\/WNL.0000000000001099","article-title":"Optimal combination secondary prevention drug treatment and stroke outcomes","volume":"84","author":"J-H Park","year":"2015","journal-title":"Neurology"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1076-7460.2007.07242.x","article-title":"Impact of combination evidence-based medical therapy on mortality following myocardial infarction in elderly patients","volume":"17","author":"EL Tay","year":"2008","journal-title":"Am J Geriatr Cardiol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1161\/01.CIR.0000112577.69066.CB","article-title":"Impact of Combination Evidence-Based Medical Therapy on Mortality in Patients with Acute Coronary Syndromes","volume":"109","author":"D Mukherjee","year":"2004","journal-title":"Circulation"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.ahj.2007.07.040","article-title":"Optimal medical therapy at discharge in patients with acute coronary syndromes: Temporal changes, characteristics, and 1-year outcome","volume":"154","author":"AT Yan","year":"2007","journal-title":"Am Heart J"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1185\/03007995.2011.590969","article-title":"Effects of a secondary prevention combination therapy with an aspirin, an ACE inhibitor and a statin on 1-year mortality of patients with acute myocardial infarction treated with a beta-blocker. Support for a polypill approach","volume":"27","author":"U Zeymer","year":"2011","journal-title":"Curr Med Res Opin"},{"key":"ref32","first-page":"1109","article-title":"Impact of combination medical therapy on mortality in patients with acute coronary syndromes","volume":"25","author":"AT Tim\u00f3teo","year":"2006","journal-title":"Rev Port Cardiol"},{"key":"ref33","first-page":"100","article-title":"The impact of optimal medical therapy at discharge on mortality in patients with coronary artery disease","volume":"14","author":"S Chen","year":"2017","journal-title":"J Geriatr Cardiol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.ahj.2005.01.058","article-title":"Impact of combined secondary prevention therapy after myocardial infarction: Data from a nationwide French registry","volume":"150","author":"N Danchin","year":"2005","journal-title":"Am Heart J"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s10654-006-9087-9","article-title":"Survival of patients discharged after acute myocardial infarction and evidence-based drug therapy","volume":"22","author":"G Gouya","year":"2007","journal-title":"Eur J Epidemiol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1136\/heartjnl-2013-304348","article-title":"Improved long-term survival in patients on combination therapies following an incident acute myocardial infarction: a longitudinal population-based study","volume":"99","author":"AS Gunnell","year":"2013","journal-title":"Heart"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1159\/000355160","article-title":"Estimating mortality in survivors of the acute coronary syndrome by the 4-drug score","volume":"127","author":"E Kopel","year":"2014","journal-title":"Cardiol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1136\/bmj.330.7499.1059","article-title":"Effect of combinations of drugs on all cause mortality in patients with ischaemic heart disease: nested case-control analysis","volume":"330","author":"J Hippisley-cox","year":"2005","journal-title":"BMJ"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/pds.3430","article-title":"Effect of evidence-based drug therapy on long-term outcomes in patients discharged after myocardial infarction: A nested case-control study in Italy","volume":"22","author":"U Kirchmayer","year":"2013","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1136\/hrt.2006.098053","article-title":"Effect of drug combinations on admission for recurrent myocardial infarction","volume":"93","author":"ME Van Der Elst","year":"2007","journal-title":"Heart"},{"key":"ref41","first-page":"679","article-title":"Infusion of fluids in emergency conditions in general practice","volume":"84","author":"T BERITIC","year":"1962","journal-title":"Lije??ni??ki Vjesn"},{"key":"ref42","first-page":"327","article-title":"Strategies for primary and secondary stroke prevention in atrial fibrillation","volume":"66","author":"C Stollberger","year":"2008","journal-title":"Neth J Med"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(05)67394-1","article-title":"Efficacy and safety of cholesterol-lowering treatment: Prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins","volume":"366","author":"CT Trialists","year":"2005","journal-title":"Lancet"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.ijcard.2017.06.106","article-title":"Trends in comorbidity in patients hospitalised for cardiovascular disease","volume":"248","author":"J Buddeke","year":"2017","journal-title":"Int J Cardiol"},{"key":"ref45","first-page":"1589","article-title":"Ibuprofen may abrogate the benefits of aspirin when used for secondary prevention of myocardial infarction","volume":"32","author":"M Hudson","year":"2005","journal-title":"J Rheumatol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.jacc.2005.01.045","article-title":"Pharmacodynamic interaction of naproxen with low-dose aspirin in healthy subjects","volume":"45","author":"ML Capone","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"ref47","article-title":"Antihypertensive agents for preventing diabetic kidney disease","author":"J Lv","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"ref48","article-title":"Fibrates for secondary prevention of cardiovascular disease and stroke","author":"D Wang","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"B Pitt","year":"2003","journal-title":"N Engl J Med"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S0895-4356(00)00242-0","article-title":"Publication and related bias in meta-analysis: Power of statistical tests and prevalence in the literature","volume":"53","author":"JAC Sterne","year":"2000","journal-title":"J Clin Epidemiol"},{"key":"ref51","article-title":"Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials","volume":"343","author":"JAC Sterne","year":"2011","journal-title":"BMJ"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0210988","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T20:48:04Z","timestamp":1588970884000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0210988"}},"subtitle":[],"editor":[{"given":"Katriina","family":"Aalto-Setala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,1,18]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,1,18]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0210988","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,18]]}}}